Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 5% ownership in Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5% | 3,115,000 | 0 | 3,115,000 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 5% | 3,115,000 | 0 | 3,115,000 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 5% | 3,115,000 | 0 | 3,115,000 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |